Head-to-head · verified 2026-08-05
Gala Health vs. Oak Longevity: prices, fine print, and the honest verdict
Published pricing is incomplete on at least one side, so this matchup compares what can be verified — disclosure, terms, model — and says plainly where you'll need figures in writing.
- Gala Health
- Tirzepatide (reported, unverified)
- $199/mo — third-party figure; excluded from rankings
- Tirzepatide, all-in at 10 mg
- Offered — no published price
- Semaglutide, all-in
- Not offered
- Membership fee
- None
- Price evidence
- Third-party-reported
- Oak Longevity
- Tirzepatide, all-in at 10 mg
- Not offered
- Semaglutide, all-in
- $133/mo
- Membership fee
- None
- Commitment
- none stated
- Cancellation
- no subscription
- Pharmacy
- not named
- Price evidence
- Source-verified
- Last verified
- 2026-08-08
Tirzepatide pricing
Gala Health carries only a reported figure — $199/mo from a competing comparison site (May 2026), never captured on a provider page — so it is listed, reviewed, and excluded from ranked comparisons pending verification. Oak Longevity does not offer tirzepatide.
Semaglutide pricing
Only Oak Longevity publishes a semaglutide price here: Semaglutide runs $133 a month all-in. Gala Health doesn't sell compounded semaglutide.
Transparency
Gala Health: Third-party-reported; dispensing pharmacy not publicly named. Oak Longevity: Source-verified (verified 2026-08-08); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.
Commitment & cancellation
Gala Health: terms not published. Oak Longevity: none stated; no subscription.
Gala Health: $199/mo reported, unverified, unranked; Oak Longevity: no published price captured; semaglutide: Oak Longevity $133; verified floor $215 (NexLife); brand rails $349–$449. Basis: all-in monthly, 10 mg maintenance, capture-dated in the dataset.
The semaglutide board
Only Oak Longevity fields a verified semaglutide price here — $133/month all-in (#1 of 19) — while Gala Health publishes no semaglutide figure we could capture. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.
The five normalizations, applied to this pair
1 · All-in, not advertised. Gala Health's reported $199 can't be normalized because no source page confirms what it includes; Oak Longevity publishes no figure to normalize. 4 · Evidence tiered. Gala Health: third-party-reported; Oak Longevity: source-verified, read 2026-08-08. 5 · Pharmacy weighed. Gala Health names no pharmacy; Oak Longevity names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.
Fine print, itemized
Gala Health: no membership — the medication figure is the billed figure. Oak Longevity: no membership — the medication figure is the billed figure; no subscription; commitment: none stated. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.
Transparency, audited
Gala Health carries third-party-reported pricing; its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Oak Longevity carries source-verified pricing (last read 2026-08-08); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.
Switching between them
Neither program locks the door: a Gala Health-to-Oak Longevity move is a new intake, a new prescription at the new pharmacy, and a written cancellation at the old shop — typically a one-to-two-week overlap if you time the last fill. What does not move with you: prepaid months, membership balances, and any dose paperwork, so re-state your current rung clearly at the new intake.
Refills, shipping, and the week-to-week reality
Past the pricing page, the operational facts are what a subscriber lives with: Gala Health: shipping, consult, and refill logistics aren’t published in our capture — ask at intake, in writing. Oak Longevity: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.
Who should pick which
Pick Gala Health if its published terms happen to fit your state, format, or timing. Pick Oak Longevity if its published terms happen to fit your state, format, or timing. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.
What verification would take
For Gala Health, ranking would require: a provider-page capture confirming the reported $199 figure and exactly what it includes; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.
If neither one fits
Two programs never exhaust the market — the nearest substitutes on the verified board are NexLife at $215 (flat, no membership, named pharmacy); Yucca Health at $258 (flat, no membership); IVIM Health at $278 (dose-scaled, $75 membership included) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.
The verdict
With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.
Quick answers
Which is cheaper, Gala Health or Oak Longevity?
Published pricing is incomplete on at least one side; the honest answer is to request current all-in figures in writing from both.
Can I switch between them?
Yes — patients move between telehealth programs routinely; you'll complete the new program's intake and prescriptions restart there. If you're also switching molecule or from compounded to brand, loop in the prescriber; our switching guide covers the clinical side.
Which is easier to cancel, Gala Health or Oak Longevity?
Gala Health: terms not published — get them in writing. Oak Longevity: no subscription Cancel in writing either way; memberships cancel separately.
Is there a brand alternative to both?
Yes — Zepbound at $299–$449 via LillyDirect/retail (about $350 on TrumpRx; ~$50 for newly eligible Medicare patients) and Wegovy at a flat $349: FDA-approved products whose prices now sit close enough to make the comparison real.